- Home
- CRMT vs AVIR Comparison
CRMT vs AVIR Comparison
Compare CRMT & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRMT
- AVIR
- Stock Information
- Founded
- CRMT 1981
- AVIR 2012
- Country
- CRMT United States
- AVIR United States
- Employees
- CRMT N/A
- AVIR N/A
- Industry
- CRMT Other Specialty Stores
- AVIR Medicinal Chemicals and Botanical Products
- Sector
- CRMT Consumer Discretionary
- AVIR Health Care
- Exchange
- CRMT Nasdaq
- AVIR Nasdaq
- Market Cap
- CRMT 266.5M
- AVIR 290.4M
- IPO Year
- CRMT N/A
- AVIR 2020
- Fundamental
- Price
- CRMT $25.77
- AVIR $3.20
- Analyst Decision
- CRMT Buy
- AVIR Hold
- Analyst Count
- CRMT 1
- AVIR 1
- Target Price
- CRMT $45.00
- AVIR $6.00
- AVG Volume (30 Days)
- CRMT 154.1K
- AVIR 436.8K
- Earning Date
- CRMT 12-04-2025
- AVIR 11-07-2025
- Dividend Yield
- CRMT N/A
- AVIR N/A
- EPS Growth
- CRMT N/A
- AVIR N/A
- EPS
- CRMT 1.61
- AVIR N/A
- Revenue
- CRMT $1,378,681,000.00
- AVIR N/A
- Revenue This Year
- CRMT $3.49
- AVIR N/A
- Revenue Next Year
- CRMT $5.72
- AVIR N/A
- P/E Ratio
- CRMT $15.86
- AVIR N/A
- Revenue Growth
- CRMT 0.64
- AVIR N/A
- 52 Week Low
- CRMT $24.85
- AVIR $2.46
- 52 Week High
- CRMT $62.72
- AVIR $4.02
- Technical
- Relative Strength Index (RSI)
- CRMT 36.10
- AVIR 56.66
- Support Level
- CRMT $24.85
- AVIR $3.04
- Resistance Level
- CRMT $28.45
- AVIR $3.30
- Average True Range (ATR)
- CRMT 1.42
- AVIR 0.12
- MACD
- CRMT 0.47
- AVIR 0.04
- Stochastic Oscillator
- CRMT 18.17
- AVIR 83.70
About CRMT America's Car-Mart Inc
America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and, in the majority of cases, a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).